November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Michael LaPelusa: Tissue and imaging biomarkers of response to neoadjuvant IO in patients with resectable HCC
Nov 14, 2024, 13:25

Michael LaPelusa: Tissue and imaging biomarkers of response to neoadjuvant IO in patients with resectable HCC

Michael LaPelusa, Hematology/Oncology fellow at MD Anderson Cancer Center, shared on X about recent paper by him as first author, titled “Tissue and Imaging Biomarkers of Response to Neoadjuvant Nivolumab or Nivolumab plus Ipilimumab in Patients with Resectable Hepatocellular Carcinoma” published on Oncology Karger.

Authors: Michael LaPelusa, Shadi Chamseddine, Hop Sanderson Tran Cao, Lianchun Xiao, Elshad Hasanov, Priya Bhosale, Hesham M. Amin, Yehia I. Mohamed, Betul Gok Yavuz, Yara Sakr, Li Xu, Ian Hu, Sunyoung S. Lee, Divya Sakamuri, Sonali Jindal, Van Nguyen, Michael A. Curran, Ryan Sun, Asif Rashid, Dan Gabriel Duda, Padmanee Sharma, Aliya Qayyum, Ahmed Omar Kaseb.

Michael LaPelusa: Tissue and imaging biomarkers of response to neoadjuvant IO in patients with resectable HCC

Out now in Oncology Karger – our paper on tissue and imaging biomarkers of response to neoadjuvant immunotherapy in patients with resectable HCC!

Excited to see if, in the near future, we can predict who will have a major pathological response.”